Introduction {#s1}
============

Small RNAs including small interfering RNAs (siRNAs) and microRNAs (miRNAs) are important regulators of gene expression via RNA interference (RNAi) pathways in many organisms ([@bib1]; [@bib51]; [@bib17]; [@bib33]). The RNAi machinery contains many proteins involved in the biogenesis and function of specific types of small RNAs ([@bib6]; [@bib51]; [@bib17]; [@bib33]). Among these are two categories that act as the core of the RNA silencing machinery: DICER (DICER-LIKE or DCL in plants) and ARGONAUTE (AGO). DICER and DCL proteins mainly function to process double-stranded or folded stem-loop precursor RNAs into small RNA duplexes. AGO proteins incorporate one strand of an siRNA duplex to form an effector complex called RNA-induced silencing complex (RISC) to regulate the stability/translatability of target RNAs or to mediate methylation of target DNA sequences ([@bib1]; [@bib51]; [@bib33]; [@bib36]; [@bib25]; [@bib42]).

In plants, the RNAi machinery has undergone extensive amplification and functional specialization during evolution. For instance, the model plant *Arabidopsis thaliana* encodes four DCLs that function indistinct and yet overlapping RNAi pathways to control diverse biological processes ranging from development, response to abiotic stresses, to defense against pathogens ([@bib7]; [@bib5]; [@bib13]; [@bib49]). *Arabidopsis* encodes 10 AGOs whose functions are not all understood. Well-studied AGOs include AGO1 that mediates mRNA cleavage is critical for development, AGO4 that directs DNA methylation, and AGO2 that functions in DNA double strand break repair ([@bib2]; [@bib30]; [@bib57]; [@bib53]). AGO1 is particularly notable in that its homeostasis is controlled at the transcriptional, post-transcriptional, and post-translational levels. At the post-transcriptional level, the *AGO1* mRNA is a target of miR168. Therefore, miR168-guided cleavage of *AGO1* mRNA by AGO1 protein exerts auto-regulation. Moreover, *AGO1* is co-expressed with miR168 and AGO1 protein can stabilize miR168 post-transcriptionally ([@bib48]; [@bib47]; [@bib30]). At the post-translational level, the accumulation of AGO1 can be reduced by F-box proteins in a proteasome-independent manner through the autophagy pathway ([@bib8]; [@bib42]). The auto-regulation of AGO1 indicates that its level within a cell can be dynamic and this dynamics may significantly impact the biological activities of a plant.

RNA-mediated immunity against viruses operates in plants, fungi, invertebrates, and mammals to specifically destroy viral RNAs through the cellular RNA silencing machinery ([@bib26]; [@bib28]). In plants, it is well known that AGO1 is a major effector of antiviral RNAi; AGO1 associates with virus-derived siRNAs (vsiRNAs) and mediates the degradation of viral RNAs. Furthermore, AGO2 and AGO7 are induced during viral infection, and both proteins can bind viral siRNAs. The antiviral function of AGO2 and AGO7 requires their slicing activity ([@bib39]; [@bib51]). AGO2 is repressed by AGO1-associated miR403, and AGO1 and AGO2 appear to exert antiviral functions in a non-redundant and cooperative manner. Specifically, AGO1 functions in the first layer of antiviral RNAi; when AGO1\'s antiviral function is inhibited, a second layer is activated involving AGO2 ([@bib16]; [@bib20]; [@bib43]; [@bib51]; [@bib4]; [@bib56]). AGO2 also recruits miR393\* to regulate plant immunity against bacterial infection ([@bib58]). As a counter-defense strategy, some plant viruses have evolved silencing suppressors to target AGO1 ([@bib3]). Moreover, infection of many viruses can elevate the miR168 level to down-regulate AGO1, thereby nullifying this layer of host defense ([@bib46]). Thus, regulation of AGO1 by both host and viral factors plays a critical role in determining host responses to viral infection. Whether a host has positive regulators to check the viral counter-defense activities is not understood. How different AGOs have evolved to regulate plant responses to pathogen infection also remains an outstanding question ([@bib10]; [@bib9]; [@bib13]).

Rice (*Oryza sativa*) is one of the most important food crops as well as an experimental model plant for monocotyledonous plants (monocots). However, rice production and consequently food sustainability is under the constant threat of emerging and reemerging viral diseases. Rice viral pathogens are genetically diverse and many highly pathogenic viruses such as *Rice stripe Tenuivirus* (RSV, with a genome comprising 4 negative-stranded RNAs) and *Rice dwarf Phytoreovirus* (RDV, with a genome comprising 12 double-stranded RNAs) are transmitted persistently and solely by arthropod vectors ([@bib18]; [@bib40]; [@bib11]). Because of the global circulation of these vectors and lack of virus resistance germplasms, the incidence and severity of rice viral diseases in many rice-growing regions are unpredictable. Infection by multiple viruses is also a common and severe challenge for other important crops. Therefore, developing new and effective strategies to control infection by multiple viruses for a crop, especially the prevalent food crops in the monocot group such as rice, maize, and wheat that have traditionally been under-investigated, is of paramount importance for human food sustainability. Successful development of such strategies requires a knowledge base of the mechanisms of viral infection and host defense responses.

The rice genome encodes five DCLs and 19 AGOs. How different AGOs regulate antiviral RNAi in rice is not known. In this study, we report a critical role of RNAi in antiviral defense in rice under natural infection conditions, when the plants were inoculated, as in the field, by viruliferous insect vectors brown planthopper (*Laodelphax striatellus*) and leafhopper (*Nephotettix cincticeps*) that transmit RSV and RDV, respectively. Intriguingly, we found that AGO18, a member of a new AGO clade that is conserved in monocots, is specifically induced by the infection of two taxonomically different viruses and is required for the antiviral function of AGO1. Loss-of-function *ago18* mutation abolishes, whereas over-expression of AGO18 increases, the AGO1 antiviral activity. We further demonstrated that AGO18 competes with AGO1 for binding miR168, resulting in elevated levels of AGO1 in the infected plants to enable antiviral defense. Expression of an miR168-resistant *AGO1a* variant in the *ago18* background rescues or increases rice antiviral activity. The antiviral function of AGO18 requires its small RNA-binding, not slicing activity. Our findings reveal a novel mechanism AGO1 homeostasis regulation by AGO18 for antiviral defense and have significant implications in understanding the evolutionary amplification of RNA silencing mechanisms and in developing novel antiviral strategies.

Results {#s2}
=======

A role for AGO1 in rice antiviral immunity under natural infection conditions {#s2-1}
-----------------------------------------------------------------------------

Our understanding of RNAi as an antiviral defense mechanism in plants mainly comes from viral infection systems involving model plants *Arabidopsis* and *Nicotiana benthamiana* by mechanical inoculation with virions or in vitro viral RNA transcripts or by agro-infiltration with viral cDNAs. To investigate the importance of RNAi in antiviral immunity in economically important crops under natural infection conditions, we used the rice-RSV patho-system in which rice is infected by RSV through the transmission of insect vector brown planthopper.

Given the established role of AGO1 in antiviral defense in *Arabidopsis*, we tested whether AGO1 functions similarly in rice by inoculating an *ago1* RNAi line ([@bib54]) by viruliferous brown planthopper carrying RSV to recapitulate the natural infection conditions. As shown in [Figure 1A](#fig1){ref-type="fig"}, the a*go1* RNAi line, in which the expression of *AGO1s* is diminished ([Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}), was much more susceptible to RSV infection and showed more severe symptoms. Northern blots showed a remarkable increase in the accumulation of RSV genomic RNAs in the *ago1* RNAi line ([Figure 1B](#fig1){ref-type="fig"}). Since *AGO1a* and *1b* are expressed at much higher levels than *AGO1c* and *1d* in both mock-inoculated and RSV-infected rice plants ([Figure 1---figure supplement 1B,C](#fig1s1){ref-type="fig"}) ([@bib22]), we presumed that AGO1a and 1b are more important for antiviral defense. Therefore, AGO1a and 1b were characterized further in subsequent studies. We immunoprecipitated AGO1a and 1b complexes from RSV-infected or mock-treated rice plants using specific antibodies. Northern blot analyses showed that RSV vsiRNAs were readily detected in the AGO1a and AGO1b complexes ([Figure 1C](#fig1){ref-type="fig"}), suggesting that AGO1 is an effector of vsiRNA. Taking together, these data indicate a role for AGO1s in antiviral immunity under natural infection conditions in rice.10.7554/eLife.05733.003Figure 1.AGO1 participates in antiviral immunity in rice.(**A**) Symptoms of WT and *ago1* RNAi rice plants infected with RSV, pictures were taken at 6 weeks post-inoculation. Scale bars, 15 cm. (**B**) Detection of RSV genomic RNA segments in WT and *ago1* RNAi rice plants by Northern blot. The blots were hybridized with radiolabeled riboprobes specific for each RNA segment. rRNAs were stained with ethidium bromide and served as loading controls. The RNA signals were quantified and normalized to rRNAs, and the relative values were calculated by comparison with those in RSV-infected WT (arbitrarily set to 1.0). (**C**) Detection of vsiRNAs associated with AGO1a and AGO1b immunoprecipitates. The silver-stained gel shows that comparable amounts of AGO1 complexes were used for RNA preparation. The asterisks indicate the positions of AGO proteins. The position of a RNA size marker, electrophoresed in parallel, is shown to the right of the blots. U6 was also probed and served as a loading control.**DOI:** [http://dx.doi.org/10.7554/eLife.05733.003](10.7554/eLife.05733.003)10.7554/eLife.05733.004Figure 1---figure supplement 1.Characterization of rice *ago1* RNAi lines and expression profiles of rice *AGO1a*, *1b*, *1c,* and *1d*.(**A**) Detection of *AGO1a, AGO1b, AGO1c,* and *AGO1d* in WT and the *ago1* RNAi line by semi-quantitative RT-PCR. *Actin* was detected and used as a control. (**B**) Expression profiles of rice *AGO1a*, *1b*, *1c*, and *1d* in vegetative tissues (young leaf, mature leaf, and root), shoot apical meristem (SAM), panicle at six different developmental stages (P1--P6), and seeds at five different developmental stages of seed development (S1--S5) examined by microarray analysis. (**C**) Detection of *AGO1a, AGO1b, AGO1c*, and *AGO1d* in mock- or RSV-inoculated rice plants by qRT-PCR. The expression levels were normalized using the signal from *OsEF-1a*. The average (± standard deviation) values from three biological repeats of qRT-PCR are shown.**DOI:** [http://dx.doi.org/10.7554/eLife.05733.004](10.7554/eLife.05733.004)

AGO18 is specifically induced by viral infection and required for antiviral immunity {#s2-2}
------------------------------------------------------------------------------------

We have previously shown that rice *AGO1* as well as *AGO18*, a member of a new AGO clade that is conserved in monocots ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}), is highly induced by viral infection ([@bib11]). Consistent with mRNA expression patterns, AGO18 protein was hardly detectable in mock-inoculated rice plants but accumulated to a high level in RSV-infected plants ([Figure 2A](#fig2){ref-type="fig"}). To further test whether RSV infection induces the transcription activity of *AGO18* promoter, we generated transgenic rice plants that express *β*-glucuronidase (GUS) under the control of *AGO18* promoter. RSV infection led to high levels of *GUS* expression in such plants as compared to the background levels in mock-inoculated plants ([Figure 2B,C](#fig2){ref-type="fig"}). These data demonstrate that RSV infection, but not insect vector feeding, induced *AGO18* expression at the transcriptional level.10.7554/eLife.05733.005Figure 2.AGO18 is induced by viral infection and confers antiviral immunity in rice.(**A**) Detection of AGO18 in mock- or RSV-inoculated rice plants by Western blot. Tubulin was probed and served as a loading control. (**B**) Representative GUS staining images of mock- or RSV-inoculated *AGO18p:GUS* transgenic plants. Scale bars, 5 mm. (**C**) qRT-PCR analysis of the transcript level of *GUS* in the indicated plants. The average (± standard deviation) values from three biological repeats of qRT-PCR are shown. (**D**) Symptoms of wild-type (WT) and *ago18* rice plants infected with RSV, pictures were taken at 6 weeks post-inoculation. Scale bars, 15 cm. (**E**) Detection of RSV genomic RNA segments in WT and *ago18* rice plants by Northern blot. The blots were hybridized with radiolabeled riboprobes specific for each RNA segment. rRNAs were stained with ethidium bromide and served as loading controls. The RNA signals were quantified and normalized to rRNAs, and the relative values were calculated by comparison with those in RSV-infected WT (arbitrarily set to 1.0). (**F**) Detection of RSV *CP* in the RSV-infected WT and *ago18* by qRT-PCR. The expression levels were normalized using the signal from *OsEF-1a*. The average (± standard deviation) values from three biological repeats of qRT-PCR are shown. (**G**) Symptoms of RSV-infected WT (Non-transgenic), *ago18* and transgenic lines overexpressing AGO18, pictures were taken at 6 weeks post-inoculation. Scale bars, 15 cm (upper panel) and 5 cm (lower panel). (**H**) Detection of AGO18 in mock- or RSV-inoculated plants as indicated. Tubulin was probed and served as a loading control. (**I**) Detection of RSV genomic RNA segments in the indicated plants by Northern blot. The blots were hybridized with radiolabeled riboprobes specific for each RNA segment. rRNAs were stained with ethidium bromide and served as loading controls. The RNA signals were quantified and normalized to rRNAs, and the relative values were calculated by comparison with those in RSV-infected WT (Non-transgenic) (arbitrarily set to 1.0). (**J**) Detection of RSV *CP* in the indicated RSV-infected plants by qRT-PCR. The expression levels were normalized using the signal from *OsEF-1a*. The average (± standard deviation) values from three biological repeats of qRT-PCR are shown.**DOI:** [http://dx.doi.org/10.7554/eLife.05733.005](10.7554/eLife.05733.005)10.7554/eLife.05733.006Figure 2---figure supplement 1.Phylogenetic analysis of AGO family proteins in plants.Unrooted, neighbor-joining tree was constructed by alignments of AGO protein sequences from the indicated plants.**DOI:** [http://dx.doi.org/10.7554/eLife.05733.006](10.7554/eLife.05733.006)10.7554/eLife.05733.007Figure 2---figure supplement 2.RSV CP triggers AGO18 expression.Detection of CP, P2, pC4, P4, and AGO18 in transgenic rice lines that overexpress RSV CP, P2, pC4, and P4 by Western blot analysis. Tubulin was also detected and served as a loading control.**DOI:** [http://dx.doi.org/10.7554/eLife.05733.007](10.7554/eLife.05733.007)10.7554/eLife.05733.008Figure 2---figure supplement 3.Identification of the *ago18* mutant.(**A**) A diagram showing the site of *Tos17* insertion in *AGO18* locus in the *ago18* mutant. (**B**) Upper two panels: Genotyping of the *ago18* mutant by PCR. LP: left primer; RP: right primer; LB: left T-DNA (*Tos17*) border primer. Lower two panels: RT-PCR analysis of *AGO18* expression in wild-type (WT) and *ago18* plants. *Actin* was detected and served as a control.**DOI:** [http://dx.doi.org/10.7554/eLife.05733.008](10.7554/eLife.05733.008)10.7554/eLife.05733.009Figure 2---figure supplement 4.AGO18 is required for rice resistance to RDV infection.(**A**) qRT-PCR analysis of *AGO1* and *AGO18* expression levels in mock- or RDV-inoculated WT and *ago18* plants. The expression levels were normalized using the signal from *OsEF-1a*. The average (± standard deviation) values from three biological repeats of qRT-PCR are shown. (**B**) Detection of AGO1a, AGO1b, and AGO18 proteins in mock- or RDV-inoculated WT and *ago18* plants. Tubulin was detected and served as a loading control. (**C**) Symptoms of RDV-infected WT (Non-trangenic), *ago18* and transgenic lines overexpressing AGO18, pictures were taken at 6 weeks post-inoculation. Scale bars, 15 cm (upper panel) and 5 cm (lower panel). (**D**) Detection of AGO18 in mock- or RDV-inoculated plants as indicated. Tubulin was probed and served as a loading control. (**E**) Detection of RDV genomic RNA segments in the indicated plants by Northern blot. The blots were hybridized with radiolabeled riboprobes specific for each RNA segment. rRNAs were stained with ethidium bromide and served as loading controls. The RNA signals were quantified and normalized to rRNAs, and the relative values were calculated by comparison with those in RSV-infected WT (arbitrarily set to 1.0).**DOI:** [http://dx.doi.org/10.7554/eLife.05733.009](10.7554/eLife.05733.009)

To investigate how RSV infection triggers the expression *of AGO18*, we examined the possibility that viral proteins produced during infection induce AGO18 expression. To do this, we generated transgenic rice plants that over-express Myc-tagged RSV P2, CP, pC4, and P4 proteins (Xiong et al., 2008), respectively ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). We found that AGO18 was induced only in the transgenic lines that over-expressed CP, but not in those that over-expressed three other viral proteins ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). This suggests that RSV CP is an effector to induce AGO18 expression during viral infection.

The induction of AGO18 expression by RSV infection prompted us to investigate its function in antiviral defense. We obtained a *Tos17* retrotransposon insertional mutant *ago18* (NF6013) ([Figure 2---figure supplement 3A](#fig2s3){ref-type="fig"}) from the *Tos17* database and isolated homozygous plants ([Figure 2---figure supplement 3B](#fig2s3){ref-type="fig"}). The *ago18* mutant did not exhibit notable phenotypic differences from the WT plants in growth and development but were much more sensitive to RSV infection than the WT plants ([Figure 2D](#fig2){ref-type="fig"}). Viral replication and infection rates also increased in *ago18* mutant plants ([Figure 2E,F](#fig2){ref-type="fig"}, and [Supplementary file 1A](#SD1-data){ref-type="supplementary-material"}). These results suggest that AGO18 may be dispensable for normal growth and development of rice, but is required for defense against RSV infection. Importantly, AGO1 is present in the *ago18* mutants. Therefore, these data indicate that the antiviral function of AGO1 depends on the presence of AGO18. We further over-expressed *AGO18* under the control of the *ACTIN* promoter in the WT rice background. The antiviral activity of AGO18 in the three independent transgenic lines was directly correlated with the expression levels of AGO18 ([Figure 2G--J](#fig2){ref-type="fig"}).

AGO18 was not only induced by and functioned against RSV, but also was induced by and functioned against RDV, a double-stranded RNA *Phytoreovirus* ([Figure 2---figure supplement 4](#fig2s4){ref-type="fig"}). This indicates that AGO18 is effective in positively regulating defense against a broad spectrum of viruses with diverse genome structures.

AGO18 unlikely functions as an effector of vsiRNAs {#s2-3}
--------------------------------------------------

Given that AGO1 is present in the *ago18* mutant and AGO18 is present in *ago1* RNAi plant and that both *ago18* mutant and *ago1* RNAi rice plants were very susceptible to viral infection, AGO1 and AGO18 evidently depend on each other for their antiviral activities. A key question is how this mutual dependence operates.

To investigate how AGO18 acts in antiviral defense, we first tested whether this protein may function as an effector of vsiRNAs, like AGO1. We immunoprecipitated AGO18 complexes from RSV-infected WT rice plants using AGO18 antibodies ([Figure 3A](#fig3){ref-type="fig"}). Northern blots using RSV RNA2 probes showed much weaker signals for vsiRNAs in AGO18 ([Figure 3A](#fig3){ref-type="fig"}), compared to those in AGO1a and AGO1b ([Figure 1C](#fig1){ref-type="fig"}). We further profiled small RNAs in AGO18 complexes prepared from RSV-infected plants using deep sequencing. For comparison, small RNAs in total extracts, AGO1a, and AGO1b complexes were also profiled in parallel. We found that vsiRNAs accounted for about 4.48% of the total small RNAs in RSV-infected plants and 17.37%--9.77% of those in the AGO1a and AGO1b complexes ([Figure 3B](#fig3){ref-type="fig"} and [Supplementary file 1B](#SD1-data){ref-type="supplementary-material"}), indicating that vsiRNAs are highly enriched in the AGO1 complexes. In contrast, vsiRNAs accounted for only about 2.52% of the AGO18-bound small RNAs ([Figure 3B](#fig3){ref-type="fig"} and [Supplementary file 1B](#SD1-data){ref-type="supplementary-material"}). These data suggest that AGO18 is not a major effector of vsiRNAs. Together with the finding that AGO18 is required for the antiviral activity of AGO1 (see above), this observation suggests that AGO18 very likely uses a different strategy to regulate antiviral defense response in rice.10.7554/eLife.05733.010Figure 3.AGO18 unlikely functions as an effector of vsiRNAs.(**A**) Detection of vsiRNAs in total extracts (Input) or AGO18 immunoprecipitates prepared from mock- or RSV-inoculated plants by Northern blot. The silver-stained gel shows the quality of purified AGO18 complexes. The asterisk indicates the position of AGO18. The position of an RNA size marker is shown on the right of the blot. U6 is probed and served as a loading control. (**B**) Percentage of deep sequencing reads matching vsiRNAs in total reads obtained from total extracts, AGO1a, AGO1b, and AGO18-associated small RNAs. Samples for deep sequencing were prepared from RSV-infected rice plants.**DOI:** [http://dx.doi.org/10.7554/eLife.05733.010](10.7554/eLife.05733.010)

AGO18 competes with AGO1 for miR168 to up-regulate AGO1 upon viral infection {#s2-4}
----------------------------------------------------------------------------

RSV infection increases the accumulation of miR168 as well as AGO18 ([@bib11]) ([Figure 2A--C](#fig2){ref-type="fig"} and [Figure 4A](#fig4){ref-type="fig"}), suggesting that the increased miR168 is not efficiently loaded into AGO1 and hence not effective in targeting AGO1. Intriguingly, from the small RNA deep sequencing analyses, we found that AGO18 recruited a large amount of miR168 in RSV-infected rice plants compared with AGO1a or AGO1b ([Figure 4A](#fig4){ref-type="fig"} and [Supplementary file 1C](#SD1-data){ref-type="supplementary-material"}). Given that miR168 plays a critical role in AGO1 homeostasis in plants ([@bib30]) and that the antiviral function of AGO1 requires the presence of AGO18, our observations suggest that AGO18 up-regulates AGO1 by competitively binding miR168 to enable antiviral defense.10.7554/eLife.05733.011Figure 4.AGO18 competes with AGO1 for miR168 to up-regulate AGO1 upon viral infection.(**A**) Percentage of deep sequencing reads matching the indicated miRNAs in total reads obtained from total extracts, AGO1a, AGO1b, and AGO18-associated small RNAs. Samples for deep sequencing were prepared from mock- or RSV-inoculated rice plants. (**B**) Detection of the indicated miRNAs in total extract (Input), AGO1a, AGO1b, and AGO18 complexes by Northern blot. The blots were stripped and reprobed for multiple times. The silver-stained gel shows that comparable amounts of different AGO complexes were used for RNA preparation. The asterisks indicate the positions of AGO proteins. The positions of RNA size markers are shown on the right of the blots. The RNA signals were quantified, and the relative values were calculated by comparison with those in total extracts or AGO1a complex prepared from mock-inoculated WT (arbitrarily set to 1.0). (**C**) Northern blot analysis showing miR168 from AGO1a, AGO1b, and AGO18 complexes in RSV-infected WT and *ago18* plants (upper panel). Western blot gel shows that comparable amounts of different AGO complexes were used for RNA preparation (lower panel). (**D**) qRT-PCR analysis of the levels of *AGO1a*, *AGO1b*, and *AGO18* in WT rice and *ago18* mutants with or without RSV infection. The expression levels were normalized using the signal from *OsEF-1a*. The average (± standard deviation) values from three biological repeats of qRT-PCR are shown. (**E**) Western blot showing AGO1a, AGO1b, and AGO18 protein levels in WT and *ago18* with or without RSV infection. Tubulin was probed and served as a loading control. (**F**) qRT-PCR analysis of the levels of *AGO1a*, *AGO1b*, *AGO2*, and *AGO18* in the indicated plants. The expression levels were normalized using the signal from *OsEF-1a*. The average (± standard deviation) values from three biological repeats of qRT-PCR are shown.**DOI:** [http://dx.doi.org/10.7554/eLife.05733.011](10.7554/eLife.05733.011)

Immunoprecipitation (IP)-northern blot analyses further confirmed that RSV infection of WT rice plants increased the association of miR168 with AGO18 but decreased its association with AGO1a and 1b, whereas several control miRNAs (including miR166 and miR156) showed no obvious changes ([Figure 4B](#fig4){ref-type="fig"}). Consistent with these results, in RSV-infected *ago18* mutants, where AGO18 is absent, more miR168 was now loaded into AGO1a and 1b ([Figure 4C](#fig4){ref-type="fig"}), which was correlated with the reduced expression of *AGO1* at mRNA ([Figure 4D](#fig4){ref-type="fig"}) and protein ([Figure 4E](#fig4){ref-type="fig"}) levels. Also in the *AGO18OE\#1* transgenic rice line, in which *AGO18* was overexpressed, *AGO1a* and *1b* both increased at the mRNA level ([Figure 4F](#fig4){ref-type="fig"}), likely as a result of more miR168 being loaded into AGO18. Consistent with our previous finding ([@bib11]), *AGO2* was induced by RSV infection in wild-type rice plants ([Figure 4F](#fig4){ref-type="fig"}). Intriguingly, knockout or overexpression of AGO18 did not have an obvious effect on such induction, indicating that the induction of *AGO2* by RSV infection is independent of AGO18 ([Figure 4F](#fig4){ref-type="fig"}). Thus, AGO18 specifically up-regulates AGO1 in antiviral defense.

To directly test whether AGO18 could indeed compete with AGO1 for binding miR168, we transiently expressed a miR168 precursor together with Flag-AGO1a or Flag-AGO1b in the presence or absence of Myc-AGO18 in *N. benthamiana* leaves. MiR444 was used as a control, because it is a species-specific miRNA in monocots that can be loaded by AGO1 ([@bib54]), but not by AGO18 ([Supplementary file 1C](#SD1-data){ref-type="supplementary-material"}). Results from IP-northern experiments showed that when AGO18 was co-expressed with AGO1a or AGO1b, there was a nearly five fold reduction in miR168 loading into AGO1a and AGO1b and concurrent increase in loading into AGO18 ([Figure 5](#fig5){ref-type="fig"}). The control miR444 was specifically loaded into AGO1a and 1b and co-expression of AGO18 did not decrease its loading into AGO1a and 1b ([Figure 5](#fig5){ref-type="fig"}). These data demonstrate that AGO18 can effectively compete with AGO1 for binding miR168.10.7554/eLife.05733.012Figure 5.AGO18 competes with AGO1 for miR168 in vitro.Specific AGO18--miR168 interaction was confirmed by in vitro assays in *N. benthamiana*. Constructs with the indicated combinations were introduced into *N. benthamiana* leaves for transient expression by agro-infiltration. Northern blots were conducted with total RNA (Input) and small RNAs recovered from immunoprecipitated AGO complexes (IP). Western blot analyses were done with the crude extract and aliquots of the IP products using anti-Flag or anti-Myc antibodies. The positions of RNA size markers are shown on the left of the blots. U6 was probed and served as a loading control.**DOI:** [http://dx.doi.org/10.7554/eLife.05733.012](10.7554/eLife.05733.012)

Small RNA-binding but not slicing activity of AGO18 is required for its antiviral function {#s2-5}
------------------------------------------------------------------------------------------

The above results show that AGO18 is unlikely an effector of vsiRNAs but has the novel activity of competing with AGO1 for binding miR168. To further test this, we analyzed the functions of AGO18 domains in antiviral defense. AGO family proteins contain four characteristic domains: an N-terminal domain and conserved PAZ, MID, and PIWI domains ([@bib45]; [@bib47]). The PAZ domain binds to the 3′ end of small RNAs ([@bib27]), whereas the MID domain recognizes the 5′ end ([@bib24]; [@bib34]; [@bib35]; [@bib12]). The PIWI domain adopts an RNaseH-like structure and exhibits endonuclease (slicing) activity when an Asp-Asp-His (DDH) catalytic triad is present ([@bib44]; [@bib41]).

Our analysis indicates that AGO18 also contains all of the four AGO signature domains and the DDH catalytic triad ([Figure 6A](#fig6){ref-type="fig"}). We investigated whether the small RNA binding and slicing activities of AGO18 are required for its role in antiviral defense by transgenic complementation experiments. We generated two AGO18 mutants, AGO18^Y537A/F538A^ (YF/AA) and AGO18^D833A^ (D833A). YF/AA contains alanine substitutions at two conserved residues (Y537F538) that are known to be required for small RNA binding ([@bib27]; [@bib15]; [@bib57]), whereas D833A contains an alanine substitution at the DDH catalytic triad ([@bib44]; [@bib41]; [@bib52]). We transgenically expressed WT AGO18, YF/AA, and D833A mutants under the control of the native *AGO18* promoter in the *ago18* mutant background. We then inoculated these plants with RSV by insect vector transmission. Western blots confirmed the expression of WT and mutant AGO18 in the infected transgenic plants ([Figure 6B](#fig6){ref-type="fig"}). Based on the disease symptoms ([Figure 6C](#fig6){ref-type="fig"}) and accumulation of viral genomic RNAs ([Figure 6D](#fig6){ref-type="fig"}), both WT AGO18 and D833A could mostly complement the *ago18* mutant for resistance to RSV infection, whereas the YF/AA mutant could not. These results suggest that AGO18 exerts its antiviral function mainly through small RNA binding, rather than slicing. We also measured the expression levels of *AGO1* in these transgenic lines that were infected by RSV. We found that *AGO1* expression was elevated by viral infection in the transgenic plants that express WT AGO18 or D833A mutant but not in those that express YF/AA ([Figure 6E](#fig6){ref-type="fig"}), further suggesting that the small RNA binding but not slicing activity of AGO18 is required for its role in up-regulating AGO1.10.7554/eLife.05733.013Figure 6.Small RNA-binding but not slicing activity of AGO18 is required for its antiviral function.(**A**) Domain structure of AGO18 protein. AGO18 consists of a variable N-terminal domain and conserved C-terminal PAZ, MID, and PIWI domains. The residues Y537 and F538 required for small RNA binding, and D833, D906, and H1045 required for slicing are indicated. (**B**) Detection of AGO18 protein in mock- or RSV-inoculated WT (Non-trangenic) plants as well as *ago18* mutants complemented with AGO18 and its derivatives by Western blot. Tubulin was probed and served as a loading control. (**C**) Symptoms of mock- or RSV-inoculated WT (Non-trangenic) plants as well as *ago18* mutants complemented with AGO18 or its derivatives, pictures were taken at 6 weeks post-inoculation. Scale bars, 15 cm (upper panel) and 5 cm (lower panel). (**D**) Detection of RSV genomic RNA segments in mock- or RSV-inoculated WT (Non-trangenic) plants as well as *ago18* mutants complemented with AGO18 or its derivatives by Northern blot. The blots were hybridized with radiolabeled riboprobes specific for each RNA segment. rRNAs were stained with ethidium bromide and served as loading controls. The RNA signals were quantified and normalized to rRNAs, and the relative values were calculated by comparison with those in RSV-infected WT (arbitrarily set to 1.0). (**E**) qRT-PCR analysis of the levels of *AGO1a*, *AGO1b*, and *AGO18* in RSV-infected WT plants as well as *ago18* mutants complemented with AGO18 or its derivatives. The expression levels were normalized using the signal from *OsEF-1a*. The average (± standard deviation) values from three biological repeats of qRT-PCR are shown.**DOI:** [http://dx.doi.org/10.7554/eLife.05733.013](10.7554/eLife.05733.013)

Expression of miR168-resistant *AGO1a* rescues the deficiency of *ago18* for viral resistance {#s2-6}
---------------------------------------------------------------------------------------------

The above studies demonstrated that AGO18 regulates AGO1 homeostasis by sequestering miR168 during viral infection. To further test this, we generated transgenic rice plants expressing wild type (AGO1a lines) and miR168-resistant *AGO1a* (AGO1a-Res lines) in the *ago18* background, under the control of the native *AGO1a* promoter ([Figure 7A](#fig7){ref-type="fig"}). The steady-state *AGO1a*/*AGO1a-Res* mRNA levels of both AGO1a and AGO1a-Res transgenes accumulated to higher levels relative to the *AGO1a* levels in wild-type (WT) non-transgenic and *ago18* plants ([Figure 7B](#fig7){ref-type="fig"}). It is noteworthy that *AGO1a* mRNA level was reduced by RSV infection in the AGO1a transgenic line, whereas AGO1a-Res transgenic lines had no significant reduction in *AGO1a-Res* mRNA levels upon RSV infection ([Figure 7B](#fig7){ref-type="fig"}), indicating that AGO1a is subject to regulation by miR168/AGO18. Although the transcript levels of the miR168-resistant transgene *AGO1a* markedly increased, none of these lines showed notable phenotypic differences from WT or *ago18* plants in growth and development. These transgenic lines, however, were much more resistant to RSV infection than *ago18* and AGO1a plants ([Figure 7B,C](#fig7){ref-type="fig"}). Viral replication significantly decreased in the AGO1a-Res plants ([Figure 7D](#fig7){ref-type="fig"}). Thus, AGO1 over-expression could rescue the deficiency of *ago18* for viral resistance. These data provided further compelling evidence that AGO18 functions through sequestering miR168 to up-regulate AGO1 against virus infections.10.7554/eLife.05733.014Figure 7.Transgenic expression of miR168-resistant AGO1a rescued the deficiency of *ago18* for viral resistance.(**A**) Schematic drawing of AGO1a featuring the target site of miR168. In *AGO1a* that is resistant to miR168 cleavage (*AGO1a-Res*), seven synonymous nucleotide substitutions were introduced into the miR168 target site. The resistance of *AGO1a-Res* to miR168-directed cleavage was examined by in vitro cleavage assay using purified AGO1a complex. Positions of the cleavage products are indicated by arrows. (**B**) qRT-PCR analysis of *AGO1a* and *AGO1b* expression levels in mock (−) or RSV-inoculated (+) WT, *ago18*, and transgenic plants expressing *AGO1a* or *AGO1a-Res* in the *ago18* mutant background. The expression levels were normalized using the signal from *OsEF-1a*. The average (± standard deviation) values from three biological repeats of qRT-PCR are shown. (**C**) Symptoms of mock- or RSV-inoculated WT (Non-trangenic), *ago18*, and transgenic plants expressing *AGO1a* or *AGO1a-Res* in the *ago18* mutant background. Scale bars, 15 cm. (**D**) Detection of RSV genomic RNA segments in the indicated plants by Northern blot. The blots were hybridized with radiolabeled riboprobes specific for each RNA segment. rRNAs were stained with ethidium bromide and served as loading controls. The RNA signals were quantified and normalized to rRNAs, and the relative values were calculated by comparison with those in RSV-infected WT (Non-trangenic) (arbitrarily set to 1.0).**DOI:** [http://dx.doi.org/10.7554/eLife.05733.014](10.7554/eLife.05733.014)

Based on the above results, we conclude that AGO18 regulates AGO1 homeostasis by specifically loading miR168 during viral infection. Sequestering of miR168 by AGO18 leads to increased accumulation of AGO1 to embark on an effective antiviral defense response.

Discussion {#s3}
==========

AGO proteins are at the heart of RNAi machinery. Building upon the conserved core components of the RNA silencing machinery such as DCLs and AGOs, plants have evolved extensive variants of these components, especially AGOs. This evolutionary amplification of the machinery components implies amplification/diversification in regulatory mechanisms/functions. While the roles of some AGOs in specific functions of RNA silencing in gene regulation and innate immunity have been well studied, the roles of most AGOs remain unknown or poorly understood. Besides AGO1, only the slicing function of AGO2 appears to be also important for antiviral defense in *Arabidopsis* ([@bib16]; [@bib20]; [@bib43]; [@bib51]; [@bib4]; [@bib56]). Current studies on the roles of several *Arabidopsis* AGOs in antiviral defense are dictated by the target RNA-slicing paradigm.

In the arms race between host defense and viral counter-defense, plant viruses have evolved various strategies, including encoding suppressors of RNA silencing, to interfere with different steps of the host RNA silencing defense pathways ([@bib10]; [@bib9]). In *Arabidopsis* and *N. benthamiana*, infection by many viruses leads to increased levels of *AGO1* mRNA readying the plants to combat viruses, but the viruses also simultaneously increase the expression levels of miR168 to down-regulate AGO1 to defeat host defense ([@bib46]). RSV infection of rice also leads to an increase in miR168 ([Figure 4A,B](#fig4){ref-type="fig"}) ([@bib11]). Thus, elevated miR168 expression appears to be a broad mechanism of viral counter-defense.

In this study, we discovered a novel mechanism of positive regulation of AGO1 activity by AGO18 in antiviral RNAi. We showed that AGO18 does not have antiviral function by itself, but its presence is required for the antiviral function of AGO1. AGO18 accomplishes this not via its slicing function but through its competition with AGO1 for binding miR168. This binding inhibits miR168-mediated auto-regulation of AGO1, thereby boosting the accumulation levels of AGO1 to enable antiviral function. Thus, AGO18 has evolved as a novel and dedicated positive regulator of the plant surveillance/defense system. Our findings suggest that AGO18-bound miR168 is not competent in cleaving *AGO1* mRNA in RSV-infected rice plants, albeit AGO18 contains conserved DDH motif for slicing activity. Several possible mechanisms can be considered. First, the catalytic activity of AGO18 may not be as potent as that of AGO1 due to some sequence/structure differences between these two AGOs. Second, the slicing activity of AGO18 may be repressed by a yet-to-be-identified protein that specifically interacts with AGO18. Third, the cellular compartmentation of AGO18/miR168 complex may be distinct from that of AGO1/miR168 and prevent its access to *AGO1* mRNA. Finally, AGO18 binding of miR168 may subsequently induce the degradation of miR168. It will be highly interesting to test these possibilities in future studies.

There were previous examples of competitive binding of other miRNAs between other AGOs and AGO1 in *Arabidopsis*. miR168 can be incorporated into AGO10 to decrease the translation efficiency of *AGO1* mRNA in *Arabidopsis* ([@bib29]). The *Arabidopsis* miR166/165 are significantly enriched in AGO10-bound miRNAs, preventing them from being loaded into AGO1 to fulfill their normal roles in development ([@bib59]; [@bib21]; [@bib31]). MiR390 is associated with AGO7 to mediated trans-acting siRNA biogenesis ([@bib35]), through cooperative activity of AGO1. In addition, miR408 associates with both AGO1 and AGO2 redundantly to regulate *Plantacyanin* mRNA levels ([@bib32]). This competition, however, does not affect AGO1 homeostasis. In contrast to these negative regulations of AGO1, binding of miR168 by AGO18 in infected rice plants boosts AGO1 accumulation. Thus, among mechanisms of AGO-regulation of AGO1 homeostasis or activity, the up-regulation of AGO1 via AGO18 binding of miR168 represents a novel type of mechanism. Whether other AGOs function similarly in *Arabidopsis*, rice, and other plants to up-regulate AGO1 or another AGO to impact developmental processes or defense responses is an outstanding question to be addressed in future studies. It is also noteworthy that, in addition to miR168, several miRNAs including miR528, miR159a, and miR159b were also recruited by AGO18 in RSV-infected rice plants ([Supplementary file 1C](#SD1-data){ref-type="supplementary-material"}). Thus, for AGO18, we cannot rule out the possibility that AGO18 plays regulatory roles in other capacities or has its own independent biological functions.

It is important to emphasize that most plant viruses are transmitted to plants by insect vectors under natural infection conditions in the field, and yet the vast majority of studies so far on the mechanisms of RNA silencing-mediated antiviral responses employed infection methods such as mechanical inoculation with in vitro viral RNA transcripts or virions and infiltration with agrobacteria carrying engineered viral DNAs. These studies often used viral delivery methods with much higher levels of inoculum than natural field conditions. How some of such manipulations would alter host responses remains an outstanding question. Here, we used insect vectors that carry the natural forms of viruses to inoculate plants, best reflecting what happens under field infection conditions with regard to the behavior of viruses and host responses. This is not only important to dissect the natural infection and defense mechanisms, but also important for developing effective technologies to combat viral infection under natural infection conditions. Recent studies indicated that natural infection in early stage of virus infection may trigger different host-defense reaction ([@bib14]).

AGO18 is of special interest because it has evolved as a conserved clade in monocots that encompass many important crop plants for foods and biofuels. Whether it plays a similar role in antiviral defense in other monocots warrants further investigations. From a broader perspective, we expect that further studies on the extensive RNA silencing machinery components evolved in crop plants may lead to new discoveries about their functions in shaping plant diversity with regard to phenotypes and innate immunity mechanisms. Finally, sequestering miR168 by AGO18 to regulate AGO1 homeostasis represents an evolutionary novelty. It raises the question of whether small RNA competition-based regulations between other types of proteins have also evolved to regulate different biological processes in plants and other organisms. This mechanism functions against infection by two evolutionarily distinct viruses, and likely has broader significance in resistance against more viruses in a wide range of monocots. We propose that engineering rice and other cereals to over-express AGO18 may provide a new strategy for the control of diverse viral pathogens.

Materials and methods {#s4}
=====================

Plant growth and virus inoculation {#s4-1}
----------------------------------

Plant growth and virus inoculation were essentially carried out as described ([@bib11]). Briefly, rice (*O. sativa* spp. *japonica*) seedlings were grown in a greenhouse at 28--30°C and 60 ± 5% relative humidity under natural sunlight for 4 weeks. The viruliferous (RSV and RDV-carrying) insects of *L. striatellus* and *N. cincticeps*, as well as virus-free *L. striatellus* and *N. cincticeps* (mock) were used for inoculation. After feeding 3 days, the insects were removed, and the rice seedlings were returned to the greenhouse to grow under the greenhouse conditions above. 3 weeks post-inoculation when the newly developed leaves started to exhibit viral symptoms, the whole seedlings were harvested. For each sample, at least 15--20 rice seedlings were pooled for RNA extraction.

Non-preference test {#s4-2}
-------------------

Non-preference tests were performed for all rice seedlings of the different genetic backgrounds with the two viral transmission insect vectors brown planthopper (*L. striatellus*) and leafhopper (*N. cincticeps*). Details of the procedures were described previously ([@bib19]).

Histochemical GUS staining {#s4-3}
--------------------------

Plants were infiltrated with 50 mM sodium phosphate (pH 7.0), 10 mM EDTA, and 0.5 mg/ml X-gluc (Apollo Scientific, UK), followed by incubation at 37°C in the dark overnight and then destained in 70% ethanol before photographing.

Generation of antibodies against rice AGOs {#s4-4}
------------------------------------------

Synthetic peptides AGO1aN (KKKTEPRNAGEC), AGO1bN (KKRTGSGSTGEC), and AGO18N (YHGDGERGYGRC) were used to raise rabbit polyclonal antibodies against AGO1a, AGO1b, and AGO18, respectively, essentially as described ([@bib54]; [@bib34]). The antisera were affinity purified and used for immunoprecipitation (IP) (1:50 dilution).

Constructs and transgenic lines {#s4-5}
-------------------------------

Gateway system (Invitrogen, Carlsbad, CA) was used to make binary constructs. Several destination vectors were created for transient expression in *N. benthamiana* and stable rice transformation. The binary gateway vector pMDC32 ([@bib23]) was modified to obtain rice AGO18 promoter (*p32:pAGO18*) or AGO1a promoter (*p32:pAGO1a*). Most cDNA and miRNA genes were cloned into pENTR/D vectors and *pENTR/D-Flag-AGO18D833A, YF/AA and AGO1a:miR168 Res* clones were prepared by using the QuikChange site-directed mutagenesis kit (Stratagene, La Jolla, CA). All these clones were confirmed by sequencing and transferred to the appropriate destination vectors by recombination using the Gateway LR Clonase II Enzyme mix (Invitrogen). *pCam2300:Actin1::OCS* and *pCam2300:35S::OCS* vectors ([@bib54]) were used to generate *pCam2300:Actin1::Flag*-*AGO18*, *pCam2300:35S::Myc-AGO18, Flag-AGO1a*, *Flag-AGO1b*, *miR168a,* and *miR444b*, respectively. All PCR primers are listed in [Supplementary file 1D](#SD1-data){ref-type="supplementary-material"}.

Transient expression in the *N. benthamiana* {#s4-6}
--------------------------------------------

Assays of transient expression in leaves of *N. benthamiana* were performed as described ([@bib50]). A detailed protocol is available upon request.

Western blotting {#s4-7}
----------------

Protein samples were boiled with same volume of 2× protein loading buffer at 95°C for 5 min and separated by SDS-PAGE gel. Proteins were then transferred to PVDF membranes and detected with antibodies against AGO18, AGO1a, AGO1b, MYC (11667203001, Roche, Switzerland), FLAG (F1804, Sigma--Aldrich, St. Louis, MO), and tubulin (T5168, Sigma--Aldrich).

Purification of rice AGO-containing complexes and associated small RNAs {#s4-8}
-----------------------------------------------------------------------

Rice AGO-containing complexes were immunopurified from RSV-inoculated rice plants as previously described ([@bib37]; [@bib55]). The quality of purification was examined by SDS-PAGE followed by silver staining or IP-western blotting, and the bands of expected sizes were confirmed as AGO proteins by mass spectrometry. RNAs were isolated from total cell extracts and from the purified AGO complexes by Trizol reagent (Invitrogen), resolved on a 15% denaturing PAGE gel, and visualized by SYBR-gold (Invitrogen) staining. Gel slices within the range of 18--28 nucleotides were excised, and the RNAs were eluted and purified for cloning.

Small RNA cloning and sequencing {#s4-9}
--------------------------------

Small RNA cloning for Illumina sequencing was carried out essentially as described previously ([@bib34]; [@bib55]). A detailed protocol is available upon request.

Small RNA Northern blotting {#s4-10}
---------------------------

Northern blot analysis with total sRNAs or from purified AGO complexes was performed as described before ([@bib37]). ^32^P-end labeled oligonucleotide probes complementary to sRNAs were used for Northern blots. The sequences of the probes are listed in [Supplementary file 1D](#SD1-data){ref-type="supplementary-material"}.

Quantitative RT-PCR analysis {#s4-11}
----------------------------

Total RNAs were extracted from rice plants with Trizol (Invitrogen). After removal of contaminating DNAs by digestion with RNase-free DNaseI (Promega, Madison, Wisconsin, USA), the RNAs were reverse transcribed by SuperScript III Reverse Transcriptase (Invitrogen) using oligo (dT). The cDNAs were then used as templates for quantitative PCR and RT-PCR. Quantitative PCR was performed using SYBR Green Real-time PCR Master Mix (Toyobo, Osaka, Japan). The rice *OsEF-1a* gene was detected in parallel and used as the internal control. All the other primers used are listed in [Supplementary file 1D](#SD1-data){ref-type="supplementary-material"}.

Bioinformatics analysis of small RNA data sets {#s4-12}
----------------------------------------------

The adaptor sequences in Illumina 1G sequencing reads were removed by using 'vectorstrip' in the EMBOSS package. The sRNA reads with length of 19--27 nt were mapped to the rice nuclear, chloroplastic, and mitochondrial genomes (<http://rice.plantbiology.msu.edu/>, version 6.0). The sRNAs with perfect genomic matches were used for further analysis. Rice miRNA annotations were from miRBase (<http://microrna.sanger.ac.uk/sequences>, Release14) and our previous publication ([@bib54]; [@bib11]). Statistical analysis of the sRNA data sets was done by using in-house-developed Perl scripts ([Supplementary file 2](#SD2-data){ref-type="supplementary-material"}).

miRNA cleavage assay {#s4-13}
--------------------

miRNA cleavage activity assay was performed essentially as described ([@bib37]; [@bib38]), using immunopurified rice AGO1a complex and in vitro-transcribed *AGO1a* or *AGO1a-Res* transcripts.

Accession numbers {#s4-14}
-----------------

Small RNA data sets generated in this study are deposited in the NCBI sequence read archive (SRA) (<http://www.ncbi.nlm.nih.gov/sra>) under accession number PRJNA273330.
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Major dataset {#s6-1}
-------------

The following dataset was generated:

Wu J, Yang Z, Wang Y, Zheng L, Ye R, Ji Y, Zhao S, Ji S, Liu R, Xu L, Zheng H, Zhou Y, Zhang X, Cao X, Xie L, Wu Z, Qi Y and Li Y, 2015,Small RNA populations in Argonaute complexes purified from Rice stripe Tenuivirus (RSV)-infected rice,<http://www.ncbi.nlm.nih.gov/bioproject/273330>,Publicly available at NCBI Sequence Read Archive (PRJNA273330).
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eLife posts the editorial decision letter and author response on a selection of the published articles (subject to the approval of the authors). An edited version of the letter sent to the authors after peer review is shown, indicating the substantive concerns or comments; minor concerns are not usually shown. Reviewers have the opportunity to discuss the decision before the letter is sent (see [review process](http://elifesciences.org/review-process)). Similarly, the author response typically shows only responses to the major concerns raised by the reviewers.

\[Editors' note: a previous version of this study was rejected after peer review, but the authors submitted for further consideration. The first decision letter after peer review is shown below.\]

Thank you for choosing to send your work entitled "Antiviral RNAi requires a novel cooperative activity of two distinct Argonaute proteins" for consideration at *eLife*. Your full submission has been evaluated by Detlef Weigel (Senior editor) and three peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the decision was reached after discussions between the reviewers. We regret to inform you that your work will not be considered further for publication.

All three reviewers have major but non-overlapping concerns about the manuscript. The major reservations are that:

1\) The concept described overlaps with the previously described AGO1-AGO10 competition;

2\) The study is incomplete. Some obvious experiments have not been done include (but are not restricted to) the use of miR168 resistant AGO1 mRNA and analysis of AGO2;

3\) The fact that all RNAi lines (DCL1, DCL2, DCL3a, DCL3b, DCL4, AGO1) have the same phenotype, raising the possibility that there is interference of transgene RNAi and antiviral RNAi.

*Reviewer \#1*:

The paper confirms that RNA silencing mediates defense against RSV and RDV delivered by insect vectors. [Figure 1](#fig1){ref-type="fig"} confirms that several DCL proteins and AGO1 are required as in the canonical RNA silencing pathway. [Figure 2](#fig2){ref-type="fig"} data implicates a monocot conserved AGO18 in this antiviral silencing. The AGO18 promoter is induced in infected plants and the mutants are hypersusceptible to virus infection. Conversely the overexpressing plants are less susceptible to infection than the control. However the AGO18 does not bind viral siRNA as effectively as AGO1 and a simple role of this unusual AGO in straightforward RNA silencing is ruled out. The AGO18 bound RNAs are instead enriched for miR168 relative to AGO1. The role of miR168 is to silence the mRNA for AGO1 and so the data are consistent with a model in which AGO18 is a negative regulator of a negative regulator of AGO1. Data to support this model are from: Competition experiments showing that overexpression of AGO18 competed with AGO1 for binding of overexpressed miR168 but not miR443 and from the findings that a mutant AGO18 with defective miRNA binding was not able to complement the mutant phenotype but the protein with inactivating mutations in the nuclease active site did.

Overall these are nicely executed experiments although I would say that the obvious and most direct test of the hypothesis with a miR168 resistant AGO1 message is conspicuously absent. The data also do not test the prediction that AGO18 induction in virus-infected plants would mediate overexpression of AGO1 and that the timing of the effect would precede the maximal rate of virus accumulation. The finding that the plant AGO-mediated antiviral silencing can be enhanced in virus-infected plants is not new and the decoy AGO mechanism is also not novel although it was described previously in a different context. Taking the sum of these considerations my view is that the paper in its present form is more suited to a specialist journal.

There are several interesting features in this paper that could be followed up to make a new paper that might be more appropriate to *eLife*. It would be interesting to know for example about the features of AGO18 that differentiate it from other AGO clades and to know more about the regulation of AGO18 in virus-infected plants. Specific questions would concern the role of insect vectors in the activation of this gene and the possibility (implied by [Figure 2](#fig2){ref-type="fig"}) that there is a systemic signal associated with its induction. We know about signals induced in disease resistant plants but this would be a signal in susceptible plants. Is it an RNA or perhaps it is a JA response induced by the insect vectors of the virus?

*Reviewer \#2*:

In this manuscript, Wu et al, show that AGO18, a monocot-specific member of the ARGONAUTE family, is induced during virus infection and preferentially binds to miR168, a miRNA that normally down-regulates AGO1, which has antiviral RNAi activity. Thus, AGO18 induction titrates miR168, leading to up-regulation of AGO1 and increased resistance to viruses. The data are convincing and support the authors\' conclusions.

However, the authors totally ignore the contribution of AGO2, both in the bibliographic introduction and in the development of their story. Indeed, at least five papers have shown that, in addition to AGO1, AGO2 contributes to antiviral RNAi activity ([@bib16]; [@bib51]; [@bib43]; [@bib20]; [@bib4]). None of these papers is referenced in the Introduction and only a brief sentence in the Discussion says that, in addition to AGO1, AGO2 also has catalytic activity against viral RNA, but there is no reference cited. The absence of investigation on AGO2 in this paper is a big concern, considering that the authors have previously shown that AGO2 is induced during virus infection, and actually more induced than AGO1 ([@bib11]). Could AGO18 induction also lead to AGO2 up-regulation, and by which mechanism? This question needs to be addressed.

In addition, the results obtained with the *dcl* RNAi lines are puzzling and actually raise a number of concerns regarding the RNAi strategy. Indeed, RNAi against either DCL1, DCL2, DCL3a, DCL3b or DCL4 increases infection rates. How is this possible, given the different role of each DCL? Isn\'t it that the production of very large amounts of dsRNA during RNAi somehow titrates the DCL(s) required for antiviral activity? If so, the results obtained during AGO1 RNAi are also questionable.

*Reviewer \#3*:

Small RNAs (sRNAs) including miRNAs and siRNAs are a group of non-coding RNAs that regulate expression of complementary target genes. sRNAs are loaded into AGO-centered RNA inducing silencing complexes (RISCs) and guide AGO to cleave their targets. It is well-known that plants, and possibly other organisms as well, utilize RNAi system to defense themselves from virus propagation. On the other hand, viruses encode viral suppressors to block different steps of posttranscriptional gene silencing pathway (i.e. destabilizing and inhibiting AGO proteins) to counter defense the host responses. It has been also shown that some viruses evolve a mechanism that induces expression of endogenous miR168 that happens to target AGO1 effector itself, leading to suppression of RNAi so that viruses can survive.

In this paper, Wu and collaborators studied siRNA responses of plants to the RSV infection, the authors took advantage of the RSV/RDV--Oryza sativa patho-systems. These RNA viruses infect rice by a planthopper vector and establish infection by overcoming the AGO1-mediated antiviral siRNA response in the plant. Nonetheless, the sRNA machinery is highly diversified in rice, encoding 5 DCL and 18 AGO proteins, most of which have still unknown functions. Importantly, the authors opted to use the natural insect vector of the viruses in the inoculation of the plants to mimic the natural infection conditions and be able to discern important effectors in the sRNA mediated antiviral defense. They found that one AGO protein, AGO18, is specifically upregulated by virus infection and also essential for antiviral immunity. They then tried to explore the mechanism underlying AGO18 function. They found that AGO18 bound less viral-derived siRNAs compared to canonical AGO1, leading to their proposal that AGO18 is unlikely an effector protein for viruses. Because they previously published a paper that the viral infection elevate the expression of both miR168 and AGO18, they hypothesized there might be come connection between the two events. They performed a deep-seq and found that AGO18 bound a large amount of miR168 (but not the largest group), and therefore proposed a model and evidence that Ago18 maintains AGO1 level by sequestering miR168 as an antiviral strategy.

Overall, the manuscript is interesting and presented lots of nice data, most of which are likely solid. It will advance the field, especially, understanding of the arms race between hosts and pathogens. This manuscript is amazingly an extension of a previous story that AGO10 specifically sequesters miR165/166 to antagonize the silencing activity of AGO1 ([@bib59]. Cell). However, there are some issues in the manuscript, some of them might be serious if not solved.

1\) The authors should integrate their work in the literature context. Starting from the Introduction of well-studied AGO functions, the authors selectively emphasized their own work and ignored other elegant work (i.e. AGO7-miR390; Montgomery, et al.; 2008). Another example is that the mechanism presented here is essentially the same as the AGO10-AGO1 story ([@bib59]). The only difference is AGO18-AGO1 for miR168 (which happens to feedback regulate AGO1). The way the authors wrote the manuscript suggests that their discovery is completely novel, if one does not go deep through the Discussion part.

2\) The manuscript missed one piece of important information: could sequestering of miR168 under AGO18 promoter through miRNA sponge or target mimicry rescue ago18 responses to viral infection?

3\) In [Figure 2H](#fig2){ref-type="fig"} it is apparent an increase in AGO18 levels upon RSV infection, especially in line \#5. This is unexpected given that the gene is under a constitutive promoter. Is it possible that the virus infection affects the protein stability? It is known that AGO proteins are unstable in the apo form (this is without sRNA bound), could it be possible that virus miR168 induction regulates AGO18 stability? The authors could address this issue by checking transcript and protein levels of AGO18 in OE lines before and after virus infection. Is the concurrent increase of AGO18 and miR168 upon viral infection synergetic effect?

4\) In the [Supplementary File 1C](#SD1-data){ref-type="supplementary-material"}, the highest accumulation of miRNA in AGO18 complexes is of miR528, which is more than 9-fold higher than in *AGO1b* or ∼3-fold *AGO1a* under virus infection. Given that miR528 is an important metabolic regulator during embryo development in rice, it seems very interesting to discuss its possible relationship to virus defense and whether AGO18 acts also as a decoy and not a silencing effector with this miRNA.

5\) In the Discussion part, the authors attempted to differentiate this finding from the AGO10-AGO1 weakens, instead of strengthening, their discussion, for having evidence of this phenomenon used not only for development but as an adaptive mechanism for viral defense in a distant organism as rice, makes it ubiquitous and conserved.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

Thank you for resubmitting your work entitled "Viral-Inducible Argonaute18 Confers Broad-Spectrum Virus Resistance in Rice by Sequestering A Host MicroRNA" for further consideration at *eLife*. Your revised article has been favorably evaluated by Detlef Weigel (Senior editor) and three reviewers, one of whom, David Baulcombe, is a member of the Board of Reviewing Editors. The manuscript has been improved but there are some remaining minor issues that need to be addressed before final acceptance, as outlined below:

1\) We strongly recommended removal of the *dcl* mutant analysis as the interpretation is not conclusive and the data are not required for the interpretation of the AGO18 analysis.

2\) We recommend a brief discussion of the follow points:

a\) What is the proposed fate of the AGO18 bound miR168?

b\) What is the sensing mechanism of viral RNA that triggers AGO18 expression?

10.7554/eLife.05733.018

Author response

\[Editors' note: the author responses to the first round of peer review follow.\]

*All three reviewers have major but non-overlapping concerns about the manuscript. The major reservations are that*:

*1) The concept described overlaps with the previously described AGO1-AGO10 competition*.

We feel there is a major difference between our finding and previous findings on AGO1-AGO10 competition to make it novel and interesting. As discussed in the Results section, indeed there were previous examples of competitive binding of other miRNAs between other AGOs and AGO1 in *Arabidopsis*. This competition, however, does not affect AGO1 homeostasis. In contrast to these negative regulations of AGO1 activities, binding of miR168 by AGO18 in infected rice plants directly boosts AGO1 accumulation. Thus, among mechanisms of AGO-regulation of AGO1 homeostasis or activity, the up-regulation of AGO1 via AGO18 binding of miR168 represents a novel type of mechanism. This opens up the question of whether other AGOs function similarly in *Arabidopsis*, rice and other plants to up-regulate AGO1 or another AGO to impact developmental processes or defense responses.

*2) The study is incomplete. Some obvious experiments have not been done include (but are not restricted to) the use of miR168 resistant AGO1 mRNA and analysis of AGO2*.

We have performed additional experiments to demonstrate that expression of miR168-resistant *AGO1a* gene rescued the deficiency of *ago18* for viral resistance. The results are presented as a new section (see also the new [Figure 7](#fig7){ref-type="fig"}). We have performed new experiments to show that AGO18 specifically induces AGO1 but not AGO2 ([Figure 4F](#fig4){ref-type="fig"}). Thus, AGO2 was not investigated further in current study. We have acknowledged the role of AGO2 in viral resistance in *Arabidopsis* in the text where appropriate.

*3) The fact that all RNAi lines (DCL1, DCL2, DCL3a, DCL3b, DCL4, AGO1) have the same phenotype, raising the possibility that there is interference of transgene RNAi and antiviral RNAi*.

To address this, we generated control transgenic rice plants that overexpress dsRNAs that target *pC2* (a glycoprotein) and *p4* (a viral disease related protein). In the *pC2* and *p4* RNAi plants, siRNAs accumulated at similar levels as those in the *dcl* RNAi lines ([Figure 1--figure supplement 1C](#fig1s1){ref-type="fig"}). However, the production of these siRNAs had no effect on the infection of RSV as measured by the severity of disease symptoms or the accumulation of RSV ([Figure 1--figure supplement 1D, and E](#fig1s1){ref-type="fig"}). These data establish that elevated accumulation of RSV in each *dcl* RNA line resulted specifically from the down-regulated expression of DCL. How the rice DCL1 and DCL3 may have the novel antiviral function, in contrast to their counterparts in *Arabidopsis* and other dicot models, is an outstanding question to answer in future studies.

*Reviewer \#1*:

*Overall these are nicely executed experiments although I would say that the obvious and most direct test of the hypothesis with a miR168 resistant AGO1 message is conspicuously absent*.

We have performed additional experiments to demonstrate that expression of miR168-resistant *AGO1a* gene rescued the deficiency of *ago18* for viral resistance. The results are presented as a new section in the main text (see also the new [Figure 7A, B, C and D](#fig7){ref-type="fig"}).

*The data also do not test the prediction that AGO18 induction in virus-infected plants would mediate overexpression of AGO1 and that the timing of the effect would precede the maximal rate of virus accumulation*.

We indeed have data showing that infection by both RSV ([Figure 2D and E](#fig2){ref-type="fig"}) and RDV ([Figure 2--figure supplement 3A and B](#fig2s3){ref-type="fig"}) induced AGO18 expression, which was directly correlated with increased accumulations of *AGO1a* and *1b* mRNAs and proteins. Furthermore, over-expression of AGO18 in transgenic plants led to increased expression of *AGO1a* and *1b*, but had no effect on the expression of AGO2 ([Figure 4F](#fig4){ref-type="fig"}). Thus, AGO18 can specifically up-regulate AGO1. The new data are added in the main text.

*The finding that the plant AGO-mediated antiviral silencing can be enhanced in virus-infected plants is not new and the decoy AGO mechanism is also not novel although it was described previously in a different context. Taking the sum of these considerations my view is that the paper in its present form is more suited to a specialist journal*.

We agree that the role of some AGOs in antiviral defense has been well demonstrated. However, our findings indicate that we are still far from understanding the mechanisms and that the field is still open for important new discoveries. We would like to discuss the novelty and importance of our work from three perspectives. First, to our knowledge, this is the first demonstration that the antiviral function of AGO1 requires the presence of another AGO. This represents an evolutionary novelty, at least in the monocots. Given the amplification and diversification of AGOs and other RNA silencing machinery components, our finding adds another important new layer of regulatory mechanism for studies on the evolution and mechanisms of RNA silencing machinery.

Second, the well-studied AGO1 and AGO2 are effectors of vsiRNAs and use their slicing activity in antiviral response. In contrast, AGO18 functions in a different mechanism -- not through its slicing activity but through its small RNA binding activity. In the host defense field, this is a novel mechanism of AGO function.

Third, for the comment that "decoy AGO mechanism is also not novel", we feel there is a major difference between our finding and previous findings to make it novel and interesting. As discussed, indeed there were previous examples of competitive binding of other miRNAs between other AGOs and AGO1 in *Arabidopsis*. This competition, however, does not affect AGO1 homeostasis. In contrast to these negative regulations of AGO1 activities, binding of miR168 by AGO18 in infected rice plants directly boosts AGO1 accumulation. Thus, among mechanisms of AGO-regulation of AGO1 homeostasis or activity, the up-regulation of AGO1 via AGO18 binding of miR168 represents a novel type of mechanism. This opens up the question of whether other AGOs function similarly in *Arabidopsis*, rice and other plants to up-regulate AGO1 or another AGO to impact developmental processes or defense responses.

*There are several interesting features in this paper that could be followed up to make a new paper that might be more appropriate to* eLife*. It would be interesting to know for example about the features of AGO18 that differentiate it from other AGO clades and to know more about the regulation of AGO18 in virus-infected plants. Specific questions would concern the role of insect vectors in the activation of this gene and the possibility (implied by* [*Figure 2*](#fig2){ref-type="fig"}*) that there is a systemic signal associated with its induction. We know about signals induced in disease resistant plants but this would be a signal in susceptible plants. Is it an RNA or perhaps it is a JA response induced by the insect vectors of the virus?*

Our mock-inoculation experiments actually addressed this concern, which we should have explained in the original manuscript. Mock-inoculation with virus-free insect vectors had no effect on AGO18 expression, essentially eliminating the possibility that insect biting (and associated hormonal responses) in triggering AGO18 expression. We have discussed this in the main text.

*Reviewer \#2*:

*In this manuscript, Wu et al., show that AGO18, a monocot-specific member of the ARGONAUTE family, is induced during virus infection and preferentially binds to miR168, a miRNA that normally down-regulates AGO1, which has antiviral RNAi activity. Thus, AGO18 induction titrates miR168, leading to up-regulation of AGO1 and increased resistance to viruses. The data are convincing and support the authors\' conclusions*.

*However, the authors totally ignore the contribution of AGO2, both in the bibliographic introduction and in the development of their story. Indeed, at least five papers have shown that, in addition to AGO1, AGO2 contributes to antiviral RNAi activity (*[@bib16]*;* [@bib51]*;* [@bib43]*;* [@bib20]*;* [@bib4]*). None of these papers is referenced in the Introduction and only a brief sentence in the Discussion says that, in addition to AGO1, AGO2 also has catalytic activity against viral RNA, but there is no reference cited*.

We have added and discuss the literature on AGO2 in the main text.

*The absence of investigation on AGO2 in this paper is a big concern, considering that the authors have previously shown that AGO2 is induced during virus infection, and actually more induced than AGO1 (*[@bib11]*). Could AGO18 induction also lead to AGO2 up-regulation, and by which mechanism? This question needs to be addressed*.

We have performed new experiments to show that AGO18 specifically induces AGO1 but not AGO2 ([Figure 4F](#fig4){ref-type="fig"}).

*In addition, the results obtained with the* dcl *RNAi lines are puzzling and actually raise a number of concerns regarding the RNAi strategy. Indeed, RNAi against either DCL1, DCL2, DCL3a, DCL3b or DCL4 increases infection rates. How is this possible, given the different role of each DCL? Isn\'t it that the production of very large amounts of dsRNA during RNAi somehow titrates the DCL(s) required for antiviral activity? If so, the results obtained during AGO1 RNAi are also questionable.*

We have addressed this concern by additional experiments and revised the text in the Results section as follows: "It should be noted that studies from *Arabidopsis* showed that DCL4 and DCL2 (in the absence of DCL4) are involved in antiviral defense ([@bib7]). \[...\] How the rice DCL1 and DCL3 may have the novel antiviral function, in contrast to their counterparts in *Arabidopsis* and other dicot models, is an outstanding question to answer in future studies."

*Reviewer \#3*:

*1) The authors should integrate their work in the literature context. Starting from the Introduction of well-studied AGO functions, the authors selectively emphasized their own work and ignored other elegant work (i.e. AGO7-miR390; Montgomery, et al.; 2008). Another example is that the mechanism presented here is essentially the same as the AGO10-AGO1 story (*[@bib59]*). The only difference is AGO18-AGO1 for miR168 (which happens to feedback regulate AGO1). The way the authors wrote the manuscript suggests that their discovery is completely novel, if one does not go deep through the Discussion part*.

As we responded to a similar comment from reviewer \#1 above, we have discussed our findings in the context of previous findings in the main text. We believe our finding adds a new and important layer regulatory mechanism of AGO functions that is of high and broad interest.

*2) The manuscript missed one piece of important information*: *could sequestering of miR168 under AGO18 promoter through miRNA sponge or target mimicry rescue ago18 responses to viral infection?*

We appreciate the reviewer's great suggestion on the experiment to test whether AGO18 acts through miR168 regulation of AGO1 to confer viral resistance. We totally agree that results from the suggested experiment will be very informative. However, it takes more than one year to generate stable transgenic rice. Before we obtain these transgenic lines, we hope we can convince this reviewer that AGO18 plays its role in viral resistance through miR168 regulation of AGO1 by providing several lines of evidence: 1) AGO18 and AGO1 are both induced by RSV infection ([Figure 2A and B](#fig2){ref-type="fig"}; [Figure 4D and E](#fig4){ref-type="fig"}); 2) AGO18 competes with AGO1 for binding miR168 both in vivo ([Figure 4B and C](#fig4){ref-type="fig"}) and in vitro ([Figure 5](#fig5){ref-type="fig"}); 3) upregulation of AGO1 by viral infection is compromised in *ago18* mutant; and 4) our new data showing that the expression of miR168-resistant *AGO1a* rescued the deficiency of *ago18* for viral resistance ([Figure 7A, B, C and D](#fig7){ref-type="fig"}).

*3) In* [*Figure 2H*](#fig2){ref-type="fig"} *it is apparent an increase in AGO18 levels upon RSV infection, especially in line \#5*. *This is unexpected given that the gene is under a constitutive promoter. Is it possible that the virus infection affects the protein stability? It is known that AGO proteins are unstable in the apo form (this is without sRNA bound), could it be possible that virus miR168 induction regulates AGO18 stability? The authors could address this issue by checking transcript and protein levels of AGO18 in OE lines before and after virus infection. Is the concurrent increase of AGO18 and miR168 upon viral infection synergetic effect?*

We apologize for this confusion. We have repeated twice the Western blot experiments described in [Figure 2H](#fig2){ref-type="fig"} and realized that the lower AGO18 level in line \#5 in the original figure was most likely due to inefficient transfer of protein to the membrane. We have replaced the figure with new Western blot results ([Figure 2H](#fig2){ref-type="fig"}). As the reviewer suggested, we have also measured the mRNA and protein levels of AGO18 in OE lines before and after RSV infection by qRT-PCR and Western blot, respectively. We found that there was a mild increase in both AGO18 mRNA and protein levels in AGO18 OE lines upon RSV infection (see [Figure 2H](#fig2){ref-type="fig"} and [Author response image 1](#fig8){ref-type="fig"}). Such increase is very likely attributed to the expression of endogenous AGO18 induced by RSV.Author response image 1.

*4) In the* [*Supplementary file 1C*](#SD1-data){ref-type="supplementary-material"}*, the highest accumulation of miRNA in AGO18 complexes is of miR528, which is more than 9-fold higher than in* AGO1b *or ∼3-fold* AGO1a *under virus infection. Given that miR528 is an important metabolic regulator during embryo development in rice, it seems very interesting to discuss its possible relationship to virus defense and whether AGO18 acts also as a decoy and not a silencing effector with this miRNA.*

We have been discussed this in the main text.

*5) In the Discussion part, the authors attempted to differentiate this finding from the AGO10-AGO1 weakens, instead of strengthening, their discussion, for having evidence of this phenomenon used not only for development but as an adaptive mechanism for viral defense in a distant organism as rice, makes it ubiquitous and conserved*.

As described above, we have revised our discussions to clarify how our findings add a new layer of regulatory mechanism to AGO functions.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

We appreciate the favorable comments made by the Senior and Reviewing editors. In the revised manuscript, we have provided additional data or explanations to address some minor concerns raised by the two editors. We wish the revisions are sufficient and the manuscript is now acceptable for publication. Point-by-point responses are listed below.

*1) We strongly recommended removal of the* dcl *mutant analysis as the interpretation is not conclusive and the data are not required for the interpretation of the AGO18 analysis.*

As recommended, we have removed the data and text about the *dcl* mutant analyses.

*2) We recommend a brief discussion of the follow points*:

*a) What is the proposed fate of the AGO18 bound miR168*?

We have added the following paragraph in the Discussion: "Our findings suggest that AGO18-bound miR168 are not competent in cleaving *AGO1* mRNA in RSV-infected rice plants \[...\]. It will be highly interesting to test these possibilities in future studies."

*b) What is the sensing mechanism of viral RNA that triggers AGO18 expression*?

After submitting the manuscript, we obtained new data to address this question. We examined the possibility that viral proteins produced during infection induce AGO18 expression. To do this, we generated transgenic rice plants that over-express Myc-tagged RSV P2, CP, pC4 and P4 proteins, respectively. We found that AGO18 was induced only in the transgenic lines that over-expressed CP, but not in those that over-expressed three other viral proteins. This suggests that RSV CP is an effector to induce AGO18 expression during viral infection. These new results are included in a new supplemental figure ([Figure 2--figure supplement 2](#fig2s2){ref-type="fig"}).

[^1]: These authors contributed equally to this work.
